Intellia Therapeutics, Inc. - Common Stock (NQ:NTLA)

14.16 -0.78 (-5.22%)

Streaming Delayed Price Updated: 4:00 PM EDT, Apr 16, 2026 Add to My Watchlist

Price and Volume

Volume	3,605,233
Open	14.95
Bid (Size)	14.06 (100)
Ask (Size)	14.30 (400)
Prev. Close	14.94
Today's Range	13.88 - 14.97
52wk Range	6.730 - 28.25
Shares Outstanding	88,140,978
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

2 Healthcare Stocks to Buy and 1 to Approach With Caution ↗

April 15, 2026

Recent performances don't tell the whole story.

Via The Motley Fool

This Cathie Wood Stock Is Up 47% This Year: Is It Too Late to Buy? ↗

March 08, 2026

This run could be short-lived.

Via The Motley Fool

Performance

YTD	+53.7%	+53.7%
1 Month	+5.8%	+5.8%
3 Month	+17.8%	+17.8%
6 Month	-45.4%	-45.4%
1 Year	+92.4%	+92.4%

More News

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought ↗

March 03, 2026

Via The Motley Fool

Intellia Therapeutics Inc (NASDAQ:NTLA) Reports Strong Q4 2025 Revenue Beat and Confirms Key 2026 Pipeline Milestones ↗

February 26, 2026

Via Chartmill

Investors Eye Explosive Growth in Anti-Aging Therapies as Market Targets $420B Milestone

March 03, 2026

Via FinancialNewsMedia

Why Did NTLA Stock Jump 10% In Pre-Market Today? ↗

March 02, 2026

Via Stocktwits

Intellia (NTLA) Q4 2025 Earnings Call Transcript ↗

February 26, 2026

Via The Motley Fool

This Cathie Wood Stock Is Already Up 41% This Year, But Is It a Buy? ↗

February 07, 2026

Via The Motley Fool

NTLA Stock Jumped 13% Today – What Is The Latest FDA Action All About? ↗

January 27, 2026

Via Stocktwits

Nasdaq, S&P 500 Futures Edge Higher Ahead Of Long Weekend: Why NVDA, MU, NTLA, ASTS Are On Traders' Radar Today ↗

January 16, 2026

Via Stocktwits

Cathie Wood’s ARK Made Just One Buy Last Session — And It’s A Biotech Stock Up Nearly 30% YTD ↗

January 16, 2026

Via Stocktwits

Intellia CEO Sells $314K in Stock While Holding Over 1 Million Shares ↗

January 12, 2026

Via The Motley Fool

Biotech’s Resurgence: How a Year-End Rally and M&A Frenzy Set the Stage for 2026

December 31, 2025

Via MarketMinute

2 Beaten-Down Stocks That Will Soar in 2026, According to Wall Street ↗

December 29, 2025

Via The Motley Fool

How BridgeBio, A Top 4% Stock, Is Lining Up Dominos On Its Triple-Digit Sprint ↗

December 02, 2025

Via Investor's Business Daily

Intellia (NTLA) Q3 2025 Earnings Call Transcript ↗

November 27, 2025

Via The Motley Fool

Longevity-Focused Health Fueling U.S. Anti-Aging Products Market Projected to Reach $27 Billion By 2033

November 18, 2025

Via FinancialNewsMedia

Longevity-Focused Health Fueling U.S. Anti-Aging Products Market Projected to Reach $27 Billion By 2033

November 18, 2025

From MarketNewsUpdates.com

Via GlobeNewswire

2 Beaten-Down Stocks to Avoid Right Now ↗

November 15, 2025

Via The Motley Fool

This Bath & Body Works Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Wednesday ↗

November 12, 2025

Via Benzinga

This SPS Commerce Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Tuesday ↗

November 11, 2025

Via Benzinga

What 21 Analyst Ratings Have To Say About Intellia Therapeutics ↗

November 11, 2025

Via Benzinga

Why Gene-Editing Giants Crispr And Intellia Just Surged ↗

November 10, 2025

Via Investor's Business Daily

12 Health Care Stocks Moving In Friday's Intraday Session ↗

November 07, 2025

Via Benzinga

Intellia Therapeutics Crashes After A Patient In Its Pivotal Study Dies ↗

November 07, 2025

Via Investor's Business Daily

Frequently Asked Questions

Is Intellia Therapeutics, Inc. - Common Stock publicly traded?

Yes, Intellia Therapeutics, Inc. - Common Stock is publicly traded.

What exchange does Intellia Therapeutics, Inc. - Common Stock trade on?

Intellia Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Intellia Therapeutics, Inc. - Common Stock?

The ticker symbol for Intellia Therapeutics, Inc. - Common Stock is NTLA on the Nasdaq Stock Market

What is the current price of Intellia Therapeutics, Inc. - Common Stock?

The current price of Intellia Therapeutics, Inc. - Common Stock is 14.16

When was Intellia Therapeutics, Inc. - Common Stock last traded?

The last trade of Intellia Therapeutics, Inc. - Common Stock was at 04/16/26 04:00 PM ET

What is the market capitalization of Intellia Therapeutics, Inc. - Common Stock?

The market capitalization of Intellia Therapeutics, Inc. - Common Stock is 1.25B

How many shares of Intellia Therapeutics, Inc. - Common Stock are outstanding?

Intellia Therapeutics, Inc. - Common Stock has 1B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.